We are live on ! Find out more
CYNA

CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA

Delisted

CYNA was delisted on the 20th of October, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 60 → 0 (-60)

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $348M → $0 (-$348M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 60

Holders
–
Holders Change
-60
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
60
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AC
Aisling Capital
New York
-$45.1M
2
BHMP
Bardin Hill Management Partners
New York
-$24M
3
CC
Coastland Capital
California
-$21.3M
4
WIC
Water Island Capital
New York
-$20.8M
5
FCM
Farallon Capital Management
California
-$20.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Aisling Capital
New York
– -$45.1M -1,121,381 Closed
BHMP
2
Bardin Hill Management Partners
New York
– -$24M -596,911 Closed
CC
3
Coastland Capital
California
– -$21.3M -529,386 Closed
WIC
4
Water Island Capital
New York
– -$20.8M -517,247 Closed
FCM
5
Farallon Capital Management
California
– -$20.3M -505,000 Closed
O
6
OrbiMed
New York
– -$20.1M -499,999 Closed
MF
7
Magnetar Financial
Illinois
– -$17.1M -424,873 Closed
CS
8
Credit Suisse
Switzerland
– -$15.1M -375,346 Closed
GP
9
GLG Partners
United Kingdom
– -$15.1M -375,000 Closed
GCL
10
Glazer Capital LLC
New York
– -$13.6M -339,122 Closed
KPF
11
K2 Principal Fund
Ontario, Canada
– -$11.5M -286,023 Closed
DCM
12
DAFNA Capital Management
California
– -$9.26M -230,201 Closed
FNYS
13
First New York Securities
New York
– -$9M -223,606 Closed
PCM
14
Pentwater Capital Management
Florida
– -$8.05M -200,000 Closed
GCIA
15
Gabelli & Co Investment Advisers
New York
– -$7.22M -179,375 Closed
LIM
16
Longfellow Investment Management
Massachusetts
– -$7.04M -175,000 Closed
CI
17
Cowen Inc
New York
– -$5.83M -144,833 Closed
AA
18
AQR Arbitrage
Connecticut
– -$5.37M -133,503 Closed
OAM
19
Oxford Asset Management
United Kingdom
– -$5.07M -125,920 Closed
OM
20
Opaleye Management
Massachusetts
– -$5.03M -125,000 Closed
FLAM
21
First Light Asset Management
Minnesota
– -$4.76M -118,349 Closed
BBP
22
Banco BTG Pactual
Brazil
– -$4.51M -112,186 Closed
VOAM
23
Vertex One Asset Management
British Columbia, Canada
– -$4.3M -106,900 Closed
Morgan Stanley
24
Morgan Stanley
New York
– -$4.07M -101,186 Closed
COPPSERS
25
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$3.91M -97,230 Closed
1
2 3

CYNA Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q4 2016, worth a combined $0 — down 100% from $348M a quarter earlier.

Sellers outnumbered buyers: 60 funds closed out of CYNA and 0 opened new positions — a net loss of 60 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Aisling Capital, exiting entirely with an estimated $45.1M sold.

  • 0 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q4 2016, down from 60 in Q3 2016.
  • Funds reported $0 of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q4 2016 and 60 closed out, a net change of -60 holders.
  • The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q4 2016 was Aisling Capital, an estimated $45.1M sold.

Based on aggregated 13F filings for Q4 2016.